Case reports: red scrotal syndrome: a localized phenotypical expression of erythromelalgia

J Drugs Dermatol. 2007 Sep;6(9):935-6.

Abstract

We report a case of red scrotal syndrome responding to oral gabapentin, a neuropathic mediator that is commonly used in the treatment of primary erythromelalgia. The positive response to oral gabapentin and the resemblance of these 2 conditions supports that red scrotal syndrome is a phenotypical expression of localized primary erythromelalgia.

Publication types

  • Case Reports

MeSH terms

  • Administration, Oral
  • Amines / administration & dosage
  • Amines / therapeutic use
  • Analgesics / administration & dosage
  • Analgesics / therapeutic use
  • Cyclohexanecarboxylic Acids / administration & dosage
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Erythromelalgia / drug therapy*
  • Erythromelalgia / pathology
  • Gabapentin
  • Genital Diseases, Male / drug therapy*
  • Genital Diseases, Male / pathology
  • Humans
  • Male
  • Middle Aged
  • Scrotum / drug effects*
  • Scrotum / pathology
  • Syndrome
  • Treatment Outcome
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Analgesics
  • Cyclohexanecarboxylic Acids
  • gamma-Aminobutyric Acid
  • Gabapentin